Skip to main content
About us

About Leica Biosystems

150+ Years of Innovation

As a global leader in anatomic pathology solutions, Leica Biosystems offers the most comprehensive portfolio that spans the entire workflow from biopsy to diagnosis.

Our Mission

Advancing Cancer Diagnostics, Improving Lives


Our Vision

From translational research to patient treatment, we envision a world where comprehensive insights enrich cancer diagnosis and offer reassurance to all patients.

News & Events



Leica Biosystems and Navinci Partner to Accelerate Cancer Research Through First-Ever Fully Automated In Situ Proximity Ligation Assays

Leica Biosystems, a global leader in anatomic pathology, and Navinci, a leader in developing innovative solutions for studying protein interactions, announce a strategic collaboration to drive innovation in cancer patient care.

Read More

Update on Leica Biosystems Progress Toward In Vitro Diagnostics Regulation (IVDR) Compliance

Leica Biosystems is pleased to announce its latest update for In Vitro Diagnostics Regulation (IVDR) certification from the notified body BSI for the immunohistochemistry (IHC) portfolio.

Read More

Leica Biosystems Launches BOND-PRIME Advanced Staining Solution to Accelerate Diagnostic Productivity

Powered by Universal Access, BOND-PRIME Enables Labs to Seamlessly Adapt to Any Incoming Workflows NUSSLOCH, Germany (April 19) – Leica Biosystems announce the European launch of BOND-PRIME.

Read More

Leica Biosystems at a Glance

About US

150+ Years of Innovation

2012 - Present

New Era of Science & Technology

2005 - 2011

Global Expansion Accelerates

1989 - 2004

Structuring for Comprehensive Workflow

1930 - 1988

Novel Products Drive Company Growth

1900 - 1930

Microtomy Technology Advances Amidst Wartime Realities

1872 - 1899

The Creation of the Microtome and the Early Years of R. Jung GMBH

Download the booklet

About Danaher

Leica Biosystems is proud to be part of Danaher. Danaher’s science and technology leadership puts Leica Biosystems’ solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.